Collectively, our analysis of transcriptomics data from human gastric cancer patients and data from our in vivo gastric cancer model demonstrate the concomitant elevation of YAP1 and receptor components of the gp130/STAT3 signalling pathway during gastric cancer development. Here, STAT3 is linked to gastric cancer.